220 related articles for article (PubMed ID: 31236742)
1. Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer.
Sawada M; Oishi T; Komatsu H; Sato S; Chikumi J; Nonaka M; Kudoh A; Osaku D; Harada T
Int J Clin Oncol; 2019 Dec; 24(12):1612-1619. PubMed ID: 31236742
[TBL] [Abstract][Full Text] [Related]
2. Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.
Al-Moundhri MS; Al-Shukaili A; Al-Nabhani M; Al-Bahrani B; Burney IA; Rizivi A; Ganguly SS
World J Gastroenterol; 2008 Jun; 14(24):3879-83. PubMed ID: 18609713
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients.
Ustuner Z; Saip P; Yasasever V; Vural B; Yazar A; Bal C; Ozturk B; Ozbek U; Topuz E
Med Oncol; 2008; 25(4):394-9. PubMed ID: 18317954
[TBL] [Abstract][Full Text] [Related]
4. Serum Vascular Endothelial Growth Factor-A as a Prognostic Biomarker for Epithelial Ovarian Cancer.
Komatsu H; Oishi T; Itamochi H; Shimada M; Sato S; Chikumi J; Sato S; Nonaka M; Sawada M; Wakahara M; Umekita Y; Harada T
Int J Gynecol Cancer; 2017 Sep; 27(7):1325-1332. PubMed ID: 28557832
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
Färkkilä A; Anttonen M; Pociuviene J; Leminen A; Butzow R; Heikinheimo M; Unkila-Kallio L
Eur J Endocrinol; 2011 Jan; 164(1):115-22. PubMed ID: 21041381
[TBL] [Abstract][Full Text] [Related]
6. Serum VEGF-A and Tumor Vessel VEGFR-2 Levels Predict Survival in Caucasian but Not Asian Patients Undergoing Resection for Gastric Adenocarcinoma.
Park DJ; Seo AN; Yoon C; Ku GY; Coit DG; Strong VE; Suh YS; Lee HS; Yang HK; Kim HH; Yoon SS
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1508-15. PubMed ID: 26259755
[TBL] [Abstract][Full Text] [Related]
7. Serum vascular endothelial growth factor: a prognostic factor in cervical cancer.
Zusterzeel PL; Span PN; Dijksterhuis MG; Thomas CM; Sweep FC; Massuger LF
J Cancer Res Clin Oncol; 2009 Feb; 135(2):283-90. PubMed ID: 18626660
[TBL] [Abstract][Full Text] [Related]
8. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma.
Mitsuhashi A; Suzuka K; Yamazawa K; Matsui H; Seki K; Sekiya S
Cancer; 2005 Feb; 103(4):724-30. PubMed ID: 15637689
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and Prognostic Performance of Serum Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor 2, and Osteopontin for Gastrointestinal Cancers.
Jiang L; Hochwald S; Deng S; Chen Y; Tan C; Zhong Q; Huang H
Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775874
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor and prognosis of cervical carcinoma.
Cheng WF; Chen CA; Lee CN; Wei LH; Hsieh FJ; Hsieh CY
Obstet Gynecol; 2000 Nov; 96(5 Pt 1):721-6. PubMed ID: 11042307
[TBL] [Abstract][Full Text] [Related]
11. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix.
Takeda M; Sakuragi N; Okamoto K; Todo Y; Minobe S; Nomura E; Negishi H; Oikawa M; Yamamoto R; Fujimoto S
Acta Obstet Gynecol Scand; 2002 May; 81(5):451-7. PubMed ID: 12027820
[TBL] [Abstract][Full Text] [Related]
12. Labeling of microvessel density, lymphatic vessel density and potential role of proangiogenic and lymphangiogenic factors as a predictive/prognostic factors after radiotherapy in patients with cervical cancer.
Biedka M; Makarewicz R; Marszałek A; Sir J; Kardymowicz H; Goralewska A
Eur J Gynaecol Oncol; 2012; 33(4):399-405. PubMed ID: 23091898
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
Nishida N; Yano H; Komai K; Nishida T; Kamura T; Kojiro M
Cancer; 2004 Sep; 101(6):1364-74. PubMed ID: 15368324
[TBL] [Abstract][Full Text] [Related]
14. Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer.
Chang YT; Chang MC; Wei SC; Tien YW; Hsu C; Liang PC; Tsao PN; Jan IS; Wong JM
Pancreas; 2008 Aug; 37(2):145-50. PubMed ID: 18665074
[TBL] [Abstract][Full Text] [Related]
15. Circulating vascular endothelial growth factors and their soluble receptors in pre-invasive, invasive and recurrent cervical cancer.
Kuemmel S; Thomas A; Landt S; Fuger A; Schmid P; Kriner M; Blohmer JU; Sehouli J; Schaller G; Lichtenegger W; Köninger A; Fuchs I
Anticancer Res; 2009 Feb; 29(2):641-5. PubMed ID: 19331214
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer.
Hashimoto I; Kodama J; Seki N; Hongo A; Yoshinouchi M; Okuda H; Kudo T
Br J Cancer; 2001 Jul; 85(1):93-7. PubMed ID: 11437408
[TBL] [Abstract][Full Text] [Related]
17. Decreased serum angiogenin level in Alzheimer's disease.
Kim YN; Kim DH
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):116-20. PubMed ID: 22449478
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
19. Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival.
Jia JB; Zhuang PY; Sun HC; Zhang JB; Zhang W; Zhu XD; Xiong YQ; Xu HX; Tang ZY
J Cancer Res Clin Oncol; 2009 Jun; 135(6):847-54. PubMed ID: 19066962
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
